Skip to main content

Day: June 25, 2024

KVH Signs Pooled Data Agreement with Starlink

Company also expands portfolio of available Starlink terminals to deliver more options and versatility to maritime users MIDDLETOWN, R.I., June 25, 2024 (GLOBE NEWSWIRE) — KVH Industries, Inc. (Nasdaq: KVHI), today announced a greatly expanded relationship with Starlink through a bulk data distribution agreement with Starlink. The new agreement offers KVH increased flexibility in the development and sales of custom, cost-effective airtime plans using Starlink’s mobile priority service. Under the agreement, KVH prepaid for access to a large block of Starlink data at favorable rates over a period of more than a year. In addition, KVH has added the Starlink Standard flat-panel terminals to its product offering alongside the Flat High Performance maritime terminal. “We are very excited to expand our Starlink portfolio, both with new...

Continue reading

NFI subsidiary Alexander Dennis receives largest single order of zero-emission buses ever, 244 next-generation electric buses from Stagecoach

LARBERT, United Kingdom, June 25, 2024 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI or the Company), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, subsidiary Alexander Dennis Limited (Alexander Dennis) today announced that it has taken a firm order from transport group Stagecoach for 244 of its next-generation zero-emission buses. Stagecoach supported numerous local authorities across England in successful bids to the second round of the UK Government’s Zero-Emission Regional Bus Areas scheme (ZEBRA 2). Following the funding award, the group has now been able to place the largest single order of Alexander Dennis’ zero-emission buses to date. 180 new Enviro400EV double deckers will join similar vehicles bought by Stagecoach with earlier ZEBRA 1 funding...

Continue reading

Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren

For its Fourth Annual Collectors Art Series, Breckenridge Distillery Partners with California Artist to Create Label for Its New, Limited Release, Sauternes Cask Finish Whiskey BRECKENRIDGE, Colo., June 25, 2024 (GLOBE NEWSWIRE) — Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announces its fourth edition of the Collectors Art Series, a partnership with Los Angeles based artist, Abby Wren which combines the art of blending color and blending whiskey. For the fourth edition of the Collector’s Art Series, Wren designs a whiskey label and mural in the RiNo Art District (Entrance in alley, 3537 Delgany St, Denver, CO 80216) in Denver, Colorado. In her design, Wren uses vivid colors and shapes to bring awareness to her message of...

Continue reading

Werewolf Therapeutics Highlights Initial Safety and Efficacy Data from its Ongoing Phase 1 Clinical Trial Evaluating WTX-330 in Patients with Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

– Data demonstrate that administration of WTX-330 reached therapeutically relevant exposure levels of systemically delivered IL-12 prodrug with an improved tolerability profile over historical data for rhIL-12 – – Early WTX-330 dose-escalation data demonstrated encouraging clinical activity and evidence of immune biomarker activity including an unconfirmed partial response in a metastatic melanoma patient – – Expansion arms open to checkpoint inhibitor-resistant or -naïve relapsed or refractory advanced tumor patients; additional results anticipated in the fourth quarter of 2024 – WATERTOWN, Mass., June 25, 2024 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated...

Continue reading

Genasys Lands $900K in LRAD Defense Orders from Middle East

SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced new and follow-on defense orders from the Middle East. The follow-on order is part of a previously announced foreign military sales (FMS) contract award to deploy LRAD systems on shore installations and naval ships. The combined value of the original award and the follow-on order is over $2.7M.     “International orders that have been delayed are starting to come in”, said Richard S. Danforth, Chief Executive Officer of Genasys. “FMS orders, the Puerto Rico dams project, the Common Remotely Operated Weapon Station (CROWS) Effectors program, and other LRAD and ACOUSTICS business are expected to drive record pipeline and backlog and position the Company for significant revenue growth next fiscal...

Continue reading

Guardforce AI Secures 5-Year Contract to Operate Consolidated Cash Center in Thailand, Enhancing Comprehensive Service Capabilities Along with AI Solutions for Retail Clients

New York, NY, June 25, 2024 (GLOBE NEWSWIRE) — Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), an integrated security, AI and Robot-as-a-Service (RaaS) provider, today announced Guardforce Cash Solutions Security (Thailand) Company (“GFCS”), a subsidiary of Guardforce AI, has successfully secured a 5-year contract to operate Consolidated Cash Center (“CCC”) in Chiangmai on behalf of the Bank of Thailand (“BOT”), commencing at the end of 2024. Prior to winning the contract in Chiangmai, GFCS had already secured multiple 5-year contracts to operate CCCs in Ubonratchathani, Phitsanulok, Hadyai, and Khon Kaen over the past three years. With the addition of Chiangmai CCC, GFCS will become the largest CCC operator on behalf of BOT, managing five CCCs in total, which accounts for 50% of BOT’s...

Continue reading

Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day

Company will discuss recent corporate updates, including compelling preclinical data from Rejuva® pancreatic gene therapy platform, which was named top abstract at American Diabetes Association’s 84th Scientific Session BURLINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, and Dr. Timothy Kieffer, CSO of Fractyl Health, will participate in a virtual fireside chat at the upcoming Piper Sandler 2nd Annual Virtual Obesity Day on Wednesday, June 26, 2024 at 9:30 a.m. EDT. The Company will discuss the acceleration of its weight maintenance clinical study, which it recently announced, as well...

Continue reading

Skye BioScience Participating in Piper Sandler Virtual Obesity Day

SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that it will participate in the Piper Sandler Virtual Obesity Day with ADA 2024 Conference Takeaways on Wednesday, June 26, 2024. The event includes presentations by KOLs and fireside chats with companies developing obesity therapeutics. Piper Sandler clients can register for the event through their representative. Skye Bioscience Fireside Chat11:30-11:55 a.m. ETSkye Participants:Punit Dhillon, CEO & Chair Tu Diep, MSc, Chief Development Officer Chris Twitty, PhD, Chief Scientific OfficerAbout Skye Bioscience...

Continue reading

BioXcel Therapeutics Announces Positive Topline Results from Post-Marketing Requirement Study Evaluating PRN Treatment of IGALMI™ (dexmedetomidine) Sublingual Film for Agitation Associated with Bipolar Disorders or Schizophrenia

Study achieved its objective and demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with 180 mcg dose (highest approved dose) For each episode occurring over seven days, a reduction in agitation was observed and no serious adverse events were reported following treatment Results supportive of Phase 3 SERENITY and TRANQUILITY programs NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced positive topline results from a post-marketing requirement (PMR) study of IGALMI™ (dexmedetomidine) sublingual film that demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with the 180 mcg dose after seven days of PRN...

Continue reading

West Red Lake Gold Strengthens Management Team

VANCOUVER, British Columbia, June 25, 2024 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or “WRLG” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce the appointment of Jason Billan as Vice President Corporate Development effective June 24, 2024. Mr. Billan has spent 15 years in the mining sector, with an emphasis on corporate development, strategy, financing, and executive leadership. Following an MBA at the University of Western Ontario in 2009, he spent three years in precious metals equity research at Salman Partners and RBC Capital Markets, with a coverage universe ranging from small exploration companies to large producers. In 2012, he joined Nevsun Resources as a corporate development analyst. In 2016 Nevsun acquired the Timok copper-gold project in Serbia for over US$500M before...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.